Methcathinone is a Schedule I controlled substance internationally and in the US. Illicit synthesis using potassium permanganate oxidation of ephedrine/pseudoephedrine has been associated with manganese-induced neurotoxicity resembling Parkinson's disease symptoms. Causes severe dehydration and increased perspiration requiring constant hydration to prevent rhabdomyolysis.
Build-updevelops rapidly, often within a single session; compulsive redosing common
Reseta few days for acute tolerance
Tolerance Decay
Full tolerance
2dHalf tolerance
4dBaseline
~10d
Rapid tolerance is commonly reported with repeated use over days; rough decay to baseline over ~1โ2 weeks is inferred from community reports and stimulant analogues. Data quality is limited and interindividual variability is high.